| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 08/25/2011 | US20110207773 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors |
| 08/25/2011 | US20110207730 Ion channel modulating compounds and uses thereof |
| 08/25/2011 | US20110207706 Methods for Treating Spinal Muscular Atrophy Using Tetracycline Compounds |
| 08/25/2011 | US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 08/25/2011 | CA2790403A1 Platelet-derived growth factor compositions and methods for the treatment of tendinopathies |
| 08/25/2011 | CA2790164A1 Method of treating a disease condition susceptible to baclofen therapy |
| 08/24/2011 | EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof |
| 08/24/2011 | EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines |
| 08/24/2011 | EP2358753A1 Myostatin binding proteins |
| 08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
| 08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
| 08/24/2011 | CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides |
| 08/23/2011 | US8003615 Stable vitamin B6 derivative |
| 08/23/2011 | US8003351 Activatable recombinant neurotoxins |
| 08/23/2011 | CA2492461C Fruit and/or vegetable derived composition |
| 08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/23/2011 | CA2377209C Therapeutic peptide-based constructs |
| 08/18/2011 | WO2011077252A3 Metaxalone cocrystals |
| 08/18/2011 | US20110201663 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists |
| 08/18/2011 | US20110201656 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 08/18/2011 | US20110200693 Increasing the efficiency of utilization of ingested creatine |
| 08/18/2011 | US20110200671 Method of treating a disease condition susceptible to baclofen therapy |
| 08/17/2011 | EP2357193A1 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2357004A1 NRG-2 nucleic acid molecules, polypeptides and diagnostic and therapeutical methods |
| 08/17/2011 | EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation |
| 08/17/2011 | EP2355838A2 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 08/17/2011 | EP1507558B1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/17/2011 | EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 08/17/2011 | CN1549717B Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses |
| 08/17/2011 | CN102159556A 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
| 08/17/2011 | CN102159543A Novel triazolo(4,3-a)pyridine derivatives, process for preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 08/17/2011 | CN102159235A Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use |
| 08/17/2011 | CN102154301A Preparation and application of conotoxin striatus S21a in South China Sea |
| 08/17/2011 | CN102154300A Conus lividus neurotoxin and coding sequence and use thereof |
| 08/17/2011 | CN102153625A Dominant epitopes for identification of anti-Titin antibodies and application thereof |
| 08/17/2011 | CN102153562A Spiro-oxindole compounds and their uses as therapeutic agents |
| 08/17/2011 | CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 08/17/2011 | CN102153505A Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 08/17/2011 | CN102151330A Vaccine and method for treatment of motor neurone diseases |
| 08/17/2011 | CN102150655A Scar healing element for ornamental plant |
| 08/16/2011 | US7999109 CCR9 inhibitors and methods of use thereof |
| 08/16/2011 | US7998922 Process for treating fibroses with biocompatible polymer |
| 08/16/2011 | CA2482655C Substituted indoles |
| 08/11/2011 | WO2011097500A2 The tweak/fn14 system regulates skeletal muscle atrophy and regeneration |
| 08/11/2011 | WO2011097456A2 Compositions and methods for enhanced parvovirus transduction |
| 08/11/2011 | WO2011096490A1 Imidazopyridin-2-one derivative |
| 08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | WO2011096377A1 Pyrrole compound |
| 08/11/2011 | WO2011095893A1 Synthesis of dgjnac from d-glucuronolactone and use to inhibit alpha-n-acetylgalactosaminidases |
| 08/11/2011 | US20110196021 High Affinity Nucleic Acid Ligands of Complement System Proteins |
| 08/11/2011 | US20110195932 Drug Combinations for the Treatment of Duchenne Muscular Dystrophy |
| 08/11/2011 | US20110195115 Hydrophilic amino acid-containing preparation having improved taste |
| 08/11/2011 | US20110195077 Methods and compositions using fgf23 fusion ppolypeptides |
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | CA2788983A1 Synthesis of dgjnac from d-glucuronolactone and use to inhibit alpha-n-acetylgalactosaminidases |
| 08/11/2011 | CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | CA2788682A1 Compositions and methods for enhanced parvovirus transduction |
| 08/11/2011 | CA2731282A1 Anti-fatigue composition |
| 08/11/2011 | CA2692371A1 Anti-fatigue composition |
| 08/10/2011 | EP1190074B1 Recombinant anti-cd40 antibody and uses thereof |
| 08/10/2011 | CN102149688A New benzimidazole derivatives |
| 08/10/2011 | CN102145100A Special oral preparation for treating cervical spondylosis |
| 08/10/2011 | CN102145057A Antispasmodic traditional Chinese medicine composition and preparation method thereof |
| 08/10/2011 | CN102145036A Qualitative determination method of traditional Chinese medicine lyophilized injection |
| 08/10/2011 | CN101693056B External medicine bag for treating articular osteoid diseases and using method thereof |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | CA2664300C Agent for preventing onset of post-stroke reflex sympathetic dystrophy |
| 08/09/2011 | CA2512000C Selective estrogen receptor modulator |
| 08/09/2011 | CA2451151C Carbamates of 2-heterocyclic-1,2-ethanediols |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/04/2011 | US20110190730 Methods of inducing pluripotency involving oct4 protein |
| 08/04/2011 | US20110190729 Methods of inducing pluripotency involving sox2 protein |
| 08/04/2011 | US20110190394 Carnitine granulate and methods for its production |
| 08/04/2011 | US20110190347 Methods for treating neuropathic pain |
| 08/04/2011 | US20110190317 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 08/04/2011 | US20110190249 Therapeutic methods and uses of sapogenins and their derivatives |
| 08/04/2011 | US20110190224 Non-Viral Delivery of Compounds to Mitochondria |
| 08/04/2011 | US20110189211 Stem cell populations and methods of use |
| 08/04/2011 | US20110189158 Clostridial neurotoxins with altered persistency |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/03/2011 | EP2351743A1 Bicyclic compound |
| 08/03/2011 | EP2351562A1 Solid solution of valine, isoleucine and leucine, and method for producing same |
| 08/03/2011 | EP2349287A2 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53. |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102139099A Therapeutic composition with a botulinum neurotoxin |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7988952 Condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns |
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | US20110184061 Thiocolchicine and colchicine analogs, methods of making and methods of use thereof |
| 07/28/2011 | US20110184046 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes |
| 07/28/2011 | US20110184038 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184030 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate |
| 07/28/2011 | US20110183994 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 07/28/2011 | US20110183951 Copper (1) Complex |
| 07/28/2011 | US20110183911 Method for improving neurotransmission failure using a novel agent |
| 07/28/2011 | US20110183910 Biglycan and related therapeutics and methods of use |
| 07/28/2011 | US20110183897 Variant activin receptor polypeptides |